This review considers the periodontal problems of renal transplant pat
ients with particular reference to their drug therapy and the pretrans
plant uremia. If would appear that either disease- or drug-induced imm
unosuppression affords the renal transplant patient a degree of ''prot
ection'' against periodontal breakdown. However, of more significance
to the periodontologist is the problem of drug-induced gingival overgr
owth with reference to both cyclosporin and nifedipine. Approximately
30% of dentate renal transplant patients medicated with cyclosporin al
one experience significant gingival overgrowth which requires surgical
excision. This figure increases to 40% when patients are medicated wi
th both drugs. The pathogenesis of this unwanted effect is uncertain a
nd the relationship between the expression of gingival overgrowth and
various periodontal or pharmacokinetic variables remains a contentious
issue. Clinical measures to prevent the occurrence of either cyclospo
rin- or nifedipine-induced gingival overgrowth are unsatisfactory.